DEANNA KUBIK: Open Payments
NPI 1316710775 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 53 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $833 · 2025 $929
Food & beverage: $929
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $297 |
| PFIZER INC. | 15 | $251 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Novo Nordisk Inc | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Stryker Corporation | 1 | $27 |
| HARMONY BIOSCIENCES LLC | 1 | $24 |
| Amgen Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: NURTEC ODT, VRAYLAR, PREVNAR 20, UBRELVY, QULIPTA, TRELEGY ELLIPTA, AIRSUPRA, Ozempic.
Industry payments across VA — which companies pay providers there.
